Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Mark Guinan > Profile

Mark Guinan

Affiliations

  • Director at Uphealth Inc. (UPHL), 2024-02-02
  • Director at Myovant Sciences Ltd. (MYOV), 2023-03-10
  • Executive Vice President & Cfo at Quest Diagnostics Inc (DGX), 2022-03-09
  • Sr. Vp & Cfo at Hill-Rom Holdings Inc. (HRC), 2012-12-18
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DGX $55.51 4,000 $222,023.20 44,222 2014-05-05 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DGX $121.18 22,563 $2,734,139.21 73,579 2020-12-24 Filing
DGX $120.06 59,193 $7,106,534.00 96,142 2020-12-24 Filing
DGX $118.60 8,524 $1,010,980.50 73,579 2020-06-08 Filing
DGX $117.65 18,246 $2,146,623.65 82,103 2020-06-08 Filing
DGX $116.81 45,826 $5,352,980.89 100,349 2020-06-08 Filing